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Abstract
Gut barrier function is key in maintaining a balanced response between the host and its
microbiome. The microbiota can modulate changes in gut barrier as well as metabolic and
inflammatory responses. This highly complex system involves numerous microbiota-derived
factors. The gut symbiont Akkermansia muciniphila is positively correlated with a lean phe-
notype, reduced body weight gain, amelioration of metabolic responses and restoration of
gut barrier function by modulation of mucus layer thickness. However, the molecular mecha-
nisms behind its metabolic and immunological regulatory properties are unexplored. Herein,
we identify a highly abundant outer membrane pili-like protein of A. muciniphila MucT that is
directly involved in immune regulation and enhancement of trans-epithelial resistance. The
purified Amuc_1100 protein and enrichments containing all its associated proteins induced
production of specific cytokines through activation of Toll-like receptor (TLR) 2 and TLR4.
This mainly leads to high levels of IL-10 similar to those induced by the other beneficial
immune suppressive microorganisms such as Faecalibacterium prausnitzii A2-165 and
Lactobacillus plantarum WCFS1. Together these results indicate that outer membrane
protein composition and particularly the newly identified highly abundant pili-like protein
Amuc_1100 of A. muciniphila are involved in host immunological homeostasis at the gut
mucosa, and improvement of gut barrier function.







Citation: Ottman N, Reunanen J, Meijerink M,
Pietila¨ TE, Kainulainen V, Klievink J, et al. (2017)
Pili-like proteins of Akkermansia muciniphila
modulate host immune responses and gut barrier
function. PLoS ONE 12(3): e0173004. doi:10.1371/
journal.pone.0173004
Editor: Yolanda Sanz, Instituto de Agroquimica y
Tecnologia de Alimentos, SPAIN
Received: October 12, 2016
Accepted: February 12, 2017
Published: March 1, 2017
Copyright: © 2017 Ottman et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This work was supported by Advanced
Research Grant 250172 (MicrobesInside) of the
European Research Council (https://erc.europa.eu/)
to WMdV, the Gravity (SIAM) and Spinoza grants
of the Netherlands Organization for Scientific
Research (NWO, http://www.nwo.nl/en) to WMdV,
the European Community’s Seventh Framework
Programme (FP7/2007-2013, https://ec.europa.eu/
Introduction
The human gastrointestinal (GI) tract provides a living environment for the complex and
diverse microbiota, which is involved in many metabolic, nutritional, physiological and immu-
nological interactions with the host [1].
The host immune system plays an important role in distinguishing between commensal
and pathogenic bacteria. On one hand, the immune system needs to stay alert to recognize
potential pathogens, and on the other hand, it has to tolerate the commensal bacteria inhabit-
ing the gut [2]. This homeostasis is achieved through pattern recognition receptor (PRR)
families expressed in immune cells. PRRs, such as Toll-like receptors (TLRs) and nucleotide
binding and oligomerization domain-like receptors (NLRs), identify microbe-associated
molecular patterns (MAMPs). MAMPs are molecules associated with both commensal and
pathogenic microorganisms. Another important component of the mucosal immune system
are the secretory immunoglobulins, such as IgA and IgG, which are secreted by plasma cells
and function by excluding bacteria from the epithelium [3, 4]. Defining the immune-modula-
tory capacity of members of the microbiota is essential in understanding their involvement in
the establishment of mucosal tolerance and balanced intestinal immune responses. There is
also growing evidence about the influence of the gut microbiota on the systemic immune sys-
tem, and consequently, the development of autoimmune diseases [5].
One of the key players in the colonic mucus-associated microbiota is Akkermansia mucini-
phila, which colonizes a considerable part of the human population and comprises 1–4% of
the fecal microbiota of healthy adults [6, 7]. This bacterium is highly adapted to its living envi-
ronment as it is capable of using mucin as the sole carbon and nitrogen source. Levels of A.
muciniphila have been shown to be inversely correlated with several disorders [8], such as
inflammatory bowel diseases (IBD) [9, 10], appendicitis [11], obesity [12, 13] and diabetes
[14], but not much is known about its immunological mechanism of action.
The impact of A. muciniphila on the host has been studied in (mono-associated) mice and
organoids, where most of the genes affected by the bacteria were implicated in immune and
metabolic responses [13, 15, 16]. The induction of immune response-associated genes was
most obvious in the colon of A. muciniphila colonized mice, where over 60 genes, including 16
genes encoding cluster of differentiation (CD) antigen markers and 10 genes encoding
immune cell membrane receptors were up-regulated upon exposure. The impact on host
metabolism is in line with the fact that A. muciniphila can have an inhibiting effect on obesity
and diabetes development. The abundance of A. muciniphila decreased in obese and type 2
diabetic mice, and treatment with the bacteria reversed high-fat diet induced metabolic disor-
ders, such as adipose tissue inflammation [17]. This was confirmed in a later study where A.
muciniphila-administered high-fat diet fed mice showed improved glucose tolerance and an
increase in the number of goblet cells and adipose tissue-resident CD4+ Foxp3+ regulatory T
cells [18]. Conversely to these studies implying a protective effect of A. muciniphila on intesti-
nal barrier function and immune stimulation, several mouse studies have reported increased
numbers of these mucosal bacteria in dextran sodium sulfate (DSS)-induced colitis [19–21].
This could be explained by a simple outgrowth of A. muciniphila in response to the thickening
of the mucus layer during DSS-induced colitis. A similar explanation can rationalize the obser-
vation that A. muciniphila administration in a minimal community appeared to aggravate Sal-
monella enterica Typhimurium-induced gut inflammation in a gnotobiotic mouse model [22].
The aim of this study was to characterize the immune-modulatory properties of A. mucini-
phila MucT by measuring cytokine production in human derived peripheral blood mononu-
clear cells (PBMCs) and activation of inflammatory pathways on reporter cell lines expressing
either TLR2/4/5/9 or NOD2-receptor. The immune response of A. muciniphila was compared
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to two other commensals, Faecalibacterium prausnitzii A2-165 and Lactobacillus plantarum
WCFS1. A proteomics approach was used to identify candidate-signaling molecules from bacte-
rial fractions, and a collection of these proteins was purified from overproducing Escherichia
coli clones. These proteins were tested for their capacity to induce TLR2-signaling, cytokine pro-
duction and to affect trans-epithelial resistance (TEER) in Caco-2 model system. Localization of
specific proteins was studied with immunofluorescence labeling using specific antibodies.
Materials and methods
Bacterial growth conditions
Akkermansia muciniphila MucT (ATTC BAA-835) was grown in a basal medium as described
previously [7]. The medium was supplemented with either hog gastric mucin (0.5%, Type III;
Sigma-Aldrich, St. Louis, MO, USA), a mix of sugars (D-glucose, L-fucose, N-acetylglucosa-
mine, N-acetylgalactosamine; 2.5 mM each, Sigma-Aldrich) or glucose (10 mM, Sigma-
Aldrich). The medium without mucin was supplemented with tryptone (8 g/l, Oxoid Ltd,
Basingstoke, Hampshire, England) and L-threonine (2 mM, Sigma-Aldrich). Incubations were
performed in serum bottles sealed with butyl-rubber stoppers at 37˚C under anaerobic condi-
tions provided by a gas phase of 182 kPa (1.5 atm) N2/CO2 (80/20 ratio). Growth was mea-
sured by spectrophotometer as optical density at 600 nm (OD600).
Faecalibacterium prausnitzii A2-165 was grown anaerobically at 37˚C in YCFA medium
supplemented with 33 mM glucose [23]. Lactobacillus plantarum WCFS1 was grown aerobi-
cally and Bifidobacterium breve DSM-20213 anaerobically at 37˚C in Difco™ Lactobacilli MRS
broth (Becton Dickinson, Sparks, USA).
Peripheral blood mononuclear cells assay
Peripheral blood of three healthy donors was received from the Sanquin Blood Bank, Nijmegen,
The Netherlands. Peripheral blood mononuclear cells (PBMCs) were separated from the blood
of healthy donors using Ficoll-Paque Plus gradient centrifugation according to the manufac-
turer’s protocol (Amersham biosciences, Uppsala, Sweden). After centrifugation the mononu-
clear cells were collected, washed in Iscove’s Modified Dulbecco’s Medium (IMDM) + Glutamax
(Invitrogen, Breda, The Netherlands) and adjusted to 0.5 × 106 cells/ml in IMDM + Glutamax
supplemented with penicillin (100 U/ml) (Invitrogen), streptomycin (100 μg/ml) (Invitrogen),
and 10% heat inactivated Fetal Bovine Serum (FBS, Lonza, Basel, Switzerland). PBMCs
(0.5 × 106 cells/well) were seeded in 48-well tissue culture plates.
Per donor a negative control (just medium), and a positive control (LPS from E. coli 1 μg/ml)
were used. PBMCs were stimulated with live bacteria or bacterial fractions. For the heat-killed
cells the bacterial culture was kept at 99˚C for 10 min. The ratio of PBMC to bacteria was 1:10.
Cells were incubated for 24 hours and the culture supernatants were collected for cytokine analy-
sis. Cytokine levels of IL-6, IL-8, IL-10, TNF-α, IL-1β and IL-12p70 were measured using multi-
plex analysis (Human inflammation CBA kit, Becton Dickinson) according to the manufacturer’s
protocol on a FACS CantoII (Becton Dickinson) and analyzed using BD FCAP software (Becton
Dickinson). The detection limits according to the manufacturer were as follows: 3.6 pg/ml IL-8,
7.2 pg/ml IL-1β, 2.5 pg/ml IL-6, 3.3 pg/ml IL-10, 3.7 pg/ml TNF-α, 1.9 pg/ml IL-12p70.
In vitro culture and stimulation of human HEK-Blue hTLR2/4/5/9/NOD2
cell lines
For the inflammatory pathway analysis HEK-Blue hTLR2, hTLR4, hTLR5, hTLR9 and
hNOD2 cell lines (Invivogen, CA, USA) were used. The cell lines were obtained directly from
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Invivogen where they were authenticated. The cell lines were regularly tested for contami-
nation by Mycoplasma using a PCR-based method. Stimulation of the receptors with the cor-
responding ligands activates NF-κB and AP-1, which induces the production of secreted
embryonic alkaline phosphatase (SEAP), the levels of which were measured by spectropho-
tometer (Spectramax). All cell lines were grown and subcultured up to 70–80% of confluency
using as a maintenance medium Dulbecco’s Modified Eagle Medium (DMEM) supplemented
with 4.5 g/l D-glucose, 50 U/ml penicillin, 50 μg/ml streptomycin, 100 μg/ml Normocin, 2
mM L-glutamine, and 10% (v/v) of heat-inactivated FBS. For each cell line, an immune re-
sponse experiment was carried out by seeding HEK-blue cells (volume 180 μl, cell amounts
listed in Table B in S1 File) in flat-bottom 96-well plates and stimulating them by addition of
20 μl bacterial suspensions. The concentrations of the suspensions are indicated in Fig 1. The
96-well plates were incubated for 20–24 h at 37˚C in a 5% CO2 incubator. Receptor ligands
Pam3CSK4 (10 ng/ml for hTLR2), LPS-EB (50 ng/ml for hTLR4), RecFLA-ST (0.1 ng/ml for
hTLR5), ODN 2006 (50 μM for hTLR9) and L18-MDP (0.1 ng/ml for hNOD2) were used as
positive control whereas maintenance medium without any selective antibiotics was used as
negative control. SEAP secretion was detected by measuring the OD600 at 15 min, 1 h, 2 h,
and 3 h after addition of 180 μL of QUANTI-Blue (Invivogen) to 20 μL of induced HEK-Blue
hTLR2/4/5/9/NOD2 supernatant. The data shown here are from the 1 h measurement point.
Experiments were performed in triplicate.
Transwell assay
To study the TLR2 signaling activity of secreted molecules, the bacteria were separated from
the cell line using Transwell (Corning, USA) cell culture membrane inserts (0.4 μm pore size).
Bacterial suspension (100 μl, ~4 × 107 bacteria/well) was added either directly to wells contain-
ing HEK-TLR2 cells or first to the Transwell insert compartment, which was then inserted
into the wells with HEK-TLR2 cells (volume 900 μl). The plates were incubated and SEAP
secretion measured as described above.
Bacterial filtrates
To study the size of the signaling molecules, the bacterial supernatant was filtered using filters
of different pore sizes and molecular mass cut off sizes. The following filters were used:
0.45 μm and 0.2 μm polyethersulfone syringe filters (Advanced Microdevices, Ambala Cantt.,
India), 1000 kDa Vivaspin 20 Polyethersulfone ultrafiltration unit (Sartorius, Goettingen, Ger-
many), 3K and 300K Pall Nanosep1 centrifugal device with Omega membrane (Pall corpora-
tion, Ann Arbor, Michigan), 10K Amicon1 Ultra regenerated cellulose centrifugal filter
(Merck Millipore Ltd., Cork, Ireland), Vivaspin 500 with 30,000 MWCO (Polyethersulfone)
Membrane Concentrator (Vivascience, Sartorius Group, Hannover, Germany). 500 μl of
supernatant was passed through the filter and the filtrate was used in the assays.
Bacterial fractionation method
The membranes of A. muciniphila were isolated from cultures grown with glucose as the car-
bon source with sucrose density-gradient centrifugation, as described previously [24]. The
samples were stored in 2 ml low binding tubes (Eppendorf, Hamburg, Germany) at −20˚C.
Qubit1 Protein Assay Kit (Life technologies, Oregon, USA) was used according to the manu-
facturer’s instructions to determine the protein content of cell extracts. Samples were loaded
on a 10% acrylamide separation gel (25201, Precise™ Protein Gels, Thermo Scientific, Rock-
ford, IL, USA) using the mini-PROTEAN 3 cell (Bio-Rad Laboratories, Hercules, CA, USA).
A. muciniphila proteins modulate host response
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The electrophoresis procedure was according to the manufacturer’s instructions. Gels were
stained using CBB R-250 as indicated in the protocol of the mini-PROTEAN 3 system.
In-gel digestion of proteins and purification of peptides were done following a modified ver-
sion of a protocol described previously [25]. Disulfide bridges in proteins were reduced by cov-
ering whole gels with reducing solution (10 mM dithiothreitol, pH 7.6, in 50 mM NH4HCO3),
and the gels were incubated at 60˚C for 1 h. Alkylation was performed for 1 h by adding 25 mL
of iodoacetamide solution (10 mM iodoacetamide in 100 mM Tris-HCl, pH 8.0). Gels were
thoroughly rinsed with dd H2O water in between steps. Each lane of SDS-PAGE gels was cut
Fig 1. A. muciniphila activates signaling pathways through TLR2 and TLR4. (A) TLR4 signaling by live
A. muciniphila (~107 bacteria/well), A. muciniphila supernatant (~5 μg of protein/well) and LPS isolated from
A. muciniphila (concentration corresponds to amount of LPS in ~107 A. muciniphila cells, ~105–106 EU/ml).
DMEM: medium control, LPS-EB: positive control (concentration corresponds to amount of LPS in ~107 E.
coli cells). (B) TLR2 signaling by live A. muciniphila (~107 bacteria/well), A. muciniphila supernatant (~5 μg of
protein/well) and LPS. DMEM; medium control, PAM3CSK4; positive control. (C) TLR2 signaling by live A.
muciniphila, L. plantarum, F. prausnitzii and B. breve (~106 bacteria/well). (D) TLR2 signaling in a Transwell
system compared to control (i.e. samples not separated from the cell line by a membrane, ~4 × 107 bacteria/
well). (E) TLR2 signaling by filtrated supernatant signaling molecules. (F) TLR2 signaling by A. muciniphila
bacterial fractions (1 μg of protein/well). (G) TLR2 signaling by A. muciniphila purified protein Amuc_1100
(0.01, 0.1 and 1 μg of protein/well). (H) TLR2 signaling by A. muciniphila purified proteins Amuc_0451,
Amuc_0625 and Amuc_2136 (0.1 and 1 μg of protein/well). DMEM; medium control, *, P<0.05 compared to
DMEM. All experiments were performed in triplicate and statistical analysis was performed by one-way
analysis of variance (ANOVA) followed by Tukey’s HSD if homogeneity of variance was met or Games-Howell
if variance was unequal.
doi:10.1371/journal.pone.0173004.g001
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into one slice, and the slices were cut into approximately 1 mm3 cubes and transferred to sepa-
rate 0.5 ml protein LoBind tubes (Eppendorf). Enzymatic digestion was done by adding 50 μl of
trypsin solution (5 ng/μl trypsin in 50 mM NH4HCO3) to each tube, and by incubating at room
temperature overnight with gentle shaking. Extraction of peptides was performed with manual
sonication in an ultrasonic water bath for 1 s before the supernatant was transferred to a clean
protein LoBind tube. Trifluoroacetic acid (10%) was added to the supernatant to reach a pH
between 2 and 4. The supernatant was used for LC-MS/MS analysis. Samples were measured by
nLC–MS/MS with a Proxeon EASY nLC and a LTQ-Orbitrap XL mass spectrometer as previ-
ously described [26].
LC–MS data analysis was performed as described previously [25], with false discovery rates
(FDRs) set to 0.01 on peptide and protein level, and additional result filtering (minimally 2
peptides necessary for protein identification of which at least one is unique and at least one is
unmodified). To analyze the abundance of proteins in the fractions, their label-free quantifica-
tion (LFQ) intensities were compared [27]. Non-existing LFQ intensity values due to not
enough quantified peptides were substituted with a value lower than the LFQ intensity value
for the least abundant, detected peptide.
Plasmid constructs and protein production
The genes Amuc_0451, Amuc_0625, Amuc_1100, and Amuc_2136 were amplified by PCR
without their signal sequence, with primers as specified in Table A in S1 File. PCR products of
the genes were cloned into either pET-24d or pET-26b vectors (Novagen1, Merck Millipore,
MA, USA). For genes Amuc_0451, Amuc_0625, and Amuc_1100 pET-26b was used with
restriction sites NdeI and XhoI. For Amuc_2136 gene, pET-24d was used and the PCR product
containing PciI and XhoI restriction sites was cloned at the NcoI and XhoI sites of the vector.
E. coli XL1Blue or TOP10 cells were transformed with constructed plasmids by electropora-
tion or heat shock, respectively. Cells with kanamycin resistance were selected by plating the
transformed cells on LB agar plates containing 50 μg/ml kanamycin. Plasmids isolated from
colonies on these plates were checked for having the right insert length by PCR and subse-
quently, isolated plasmids were sequenced to confirm the right insert.
E. coli BL21(DE3) cells were transformed with the right plasmid for protein expression. LB
broth containing kanamycin (50 μg/ml) was inoculated with overnight culture and grown with
shaking at 220 rpm at 37˚C until exponential phase, and protein production was induced by
adding IPTG up to 1 mM. After three hours of induction, cells were pelleted by centrifuging
10 min at 5000 g and cell pellets stored at –20˚C until lysis.
Cell pellets were resuspended and lysed using lysozyme and sonification (Sonifier 450,
Branson Ultrasonics Corporation, Danbury, CT). Supernatant was collected after centrifuga-
tion and proteins were His-tag purified by metal affinity purification under native conditions
using Ni-NTA His•Bind Resin (Novagen1, Merck Millipore, MA, USA). Elution buffer was
exchanged for a 50 mM Tris-HCl, 50 mM NaCl, pH of 7.4 buffer by using 5 ml resin bed Zeba
spin columns (Pierce, Rockford, IL, USA). After buffer exchange, protein content was mea-
sured by BCA assay (Pierce) and proteins were stored at -20˚C.
Immunofluorescence microscopy
Rabbit antibodies were raised against the purified recombinant Amuc_1100 protein and these
were used in immunomicroscopic analysis of its location in A. muciniphila. Total antibodies
raised against A. muciniphila whole cells were used as a control. The immunization was done
in Eurogentec (Seraing, Belgium) and the Laboratory Animal Centre of University of Helsinki
(Finland) as described previously [28].
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Immunofluorescence staining was used to confirm the presence of Amuc_1100 on the surface
of A. muciniphila as described previously [29]. Briefly, A. muciniphila cells were cultivated for 24
h with glucose as the carbon source, washed with phosphate-buffered saline (PBS), and fixed with
3.5% (w/v) paraformaldehyde in PBS prior to labeling with A. muciniphila whole cell antiserum
or anti-Amuc_1100 pre-immune serum as the primary antiserum and Alexa-488 (Invitrogen)-
conjugated anti-rabbit IgG (1 μg/ml) as the secondary antibody. Bacteria were then examined
with an epifluorescence microscope (Leica DM 4000B) equipped with a filter for the Alexa-488
label (excitation, 450 to 490 nm; emission, 515 nm), and images were digitally recorded using
CellP imaging software for life sciences microscopy (Soft Imaging System GmbH).
Extraction of LPS
A. muciniphila LPS was extracted using the hot phenol-water extraction method as described
previously [30], with minor modifications. Briefly, bacterial cells from 5 ml overnight cultures
were collected by centrifugation, washed once with water and resuspended into 500 μl of ultra-
pure water. The bacterial suspensions were warmed up at 65˚C and then mixed with an equal
volume of water-saturated phenol preheated to 65˚C. The mixture was incubated at 65˚C for
10 min and then transferred to ice to cool down. After centrifugation at 4˚C for 5 min, the
aqueous layer was carefully transferred to a new Eppendorf tube and the incubation with an
equal volume of hot phenol was repeated twice. After this two volumes of acetone were added
to the aqueous layer to precipitate LPS. The suspension was incubated at -20˚C for two hours
after which it was centrifuged at 4˚C for 10 minutes and the pellet was dissolved in 50 μl LPS-
free water. The quality of the LPS was checked by silver staining (Fig B in S1 File) and quantity
of the LPS was checked by EndoLISA1 Endotoxin Detection Assay (Hyglos GmbH, Bernried
am Starnberger See, Germany) according to manufacturer’s protocol.
Transepithelial Electrical Resistance (TEER) assay
Caco-2 cells (5 x 104 cells/insert) were seeded in Millicell cell culture inserts (3 μm pore size;
Merck Millipore) and grown for 8 days. The growth conditions of Caco-2 cells were as described
previously [31]. Bacterial cells were washed once with RPMI 1640, and applied onto the inserts
at OD600 of 0.25 in RPMI 1640. Purified A. muciniphila proteins Amuc_0451, Amuc_0625,
Amuc_1100, and Amuc_2136 were applied onto the inserts at concentrations of 0.05, 0.5 and
5 μg/ml. The transepithelial resistance was determined with a Millicell ERS-2 TEER meter
(Merck Millipore) from cell cultures at time points 0 h, 24 h, and 48 h after addition of bacterial
cells or proteins.
Statistical analysis
Data are expressed as means ± standard deviation. Statistical analysis of the results from the
HEK-Blue cell lines and cytokine analysis was performed by one-way analysis of variance
(ANOVA) followed by Tukey’s HSD if homogeneity of variance was met or Games-Howell if
variance was unequal. IBM SPSS software (IBM SPSS Statistics 22) was used for analysis;
p values< 0.05 were considered significant.
Results
A. muciniphila stimulates species-specific cytokine patterns when
compared to other commensals
Stimulation of peripheral blood mononuclear cells (PBMCs) with A. muciniphila MucT resulted
in induction of both anti- and pro-inflammatory cytokines (IL-1β, IL-6, IL-8, IL-10 and TNF-α).
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This induction was seen for live cells as well as for heat-killed cells and supernatant (Table 1).
Among the measured cytokines, IL-10, IL-8, IL-6 and TNF-α were the highest induced.
A. muciniphila immune stimulation in PBMCs was compared to two other established ben-
eficial gut microbes, F. prausnitzii A2-165 and L. plantarum WCFS1. The stimulation of
PBMCs led to a microbe-specific pattern of all tested microorganisms. In comparison to F.
prausnitzii, A. muciniphila induced higher levels of IL-6 and IL-8, while levels of IL-10 were
similar and levels of TNF-α were lower (Table 1, Fig 2A–2D). Compared to L. plantarum, A.
muciniphila induced higher levels of IL-6, IL-8 and IL-10 but less TNF-α (Table 1, Fig 2A–
2D). PBMCs were also stimulated with the supernatants of these bacteria leading to a markedly
different cytokine response for IL-10 and TNF-α, whereas IL-8 and IL-6 showed more similar
patterns compared to live bacteria (Fig 2E–2H). Remarkably, A. muciniphila supernatant
induced significantly more IL-10 than F. prausnitzii supernatant and more IL-10 and TNF-α
than L. plantarum supernatant (Fig 2E and 2F). When analysing the TNF-α/IL-10 ratio as a
measure of inflammation it was found that A. muciniphila had a low inflammatory potential in
comparison to F. prausnitzii and L. plantarum (Fig A in S1 File).
A. muciniphila activates the NF-κB pathway through TLR4 and TLR2
receptors
To determine which intestinal receptors are involved in immune stimulation of A. mucini-
phila, reporter cell lines expressing TLR2, TLR4, TLR5, TLR9 or NOD2 receptors were
Table 1. Effect of bacteria and bacterial fractions on cytokine production of human PBMCs.
Cytokine Live Heat-killed Supernatant Live Live
(pg/ml) A. muciniphila A. muciniphila A. muciniphila F. prausnitzii L. plantarum
IL-1β 894 ± 298 392 ± 71 1650 ± 510 870 ± 301 894 ± 298
IL-6 18029 ± 309 13477 ± 2014 23225 ± 8102 10178 ± 2648 7028 ± 2812
IL-8 60018 ± 18229 54230 ± 9030 86171 ± 32298 48354 ± 10526 33085 ± 16760
IL-10 823 ± 310 638 ± 118 1221 ± 310 834 ± 388 333 ± 215
TNF-α 1920 ± 349 957 ± 568 2095 ± 1249 5545 ± 2615 5459 ± 2830
IL-12p70 < 2 < 2 < 2 < 2 253 ± 293
Supernatant filtrates
Cytokine (pg/ml) 10 kDa filtrate 30 kDa filtrate 100 kDa filtrate 300 kDa filtrate 1000 kDa filtrate
IL-1β < 8 < 8 62 ± 29 678 ± 350 949 ± 522
IL-6 22 ± 23 569 ± 430 2556 ± 1049 18697 ± 7097 18717 ± 7326
IL-8 4321 ± 4530 11928 ± 7128 29040 ± 14973 74208 ± 28348 73695 ± 36442
IL-10 < 4 6 ± 4 43 ± 28 937 ± 287 1215 ± 379
TNF-α < 4 37 ± 48 247 ± 255 1476 ± 849 1188 ± 930
IL-12p70 < 2 < 2 < 2 < 2 < 2
Sucrose density-gradient separated fractions and purified Amuc_1100 Controls
Cytokine Fraction 1 Fraction 2 Amuc_1100 Medium LPS
(pg/ml) (4.5 μg/ml) (4.5 μg/ml) (4.5 μg/ml) (1 μg/ml)
IL-1β 437 ± 225 < 8 504 ± 227 < 8 324 ± 121
IL-6 9312 ± 3329 414 ± 364 12508 ± 2362 < 4 13299 ± 5460
IL-8 64877 ± 19528 13339 ± 5039 45432 ± 12507 489 ± 291 60063 ± 5765
IL-10 941 ± 404 21 ± 18 526 ± 180 < 4 319 ± 157
TNF-α 2165 ± 883 60 ± 35 1317 ± 885 < 4 1392 ± 622
IL-12p70 < 2 < 2 < 2 < 2 < 2
Data are presented as mean ± SD, n = 3 donors. Per donor a negative control (just medium), and a positive control (LPS from E. coli 1 μg/ml) were used.
doi:10.1371/journal.pone.0173004.t001
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Fig 2. Effect of A. muciniphila, F. prausnitzii and L. plantarum on cytokine production of human PBMCs. IL-10 (A), TNF-α (B), IL-8
(C) and IL-6 (D) responses of human PBMCs (n = 3 donors) stimulated with A. muciniphila, F. prausnitzii and L. plantarum live cells. IL-10
(E), TNF-α (F), IL-8 (G) and IL-6 (H) responses of human PBMCs (n = 3 donors) stimulated with A. muciniphila, F. prausnitzii and L.
plantarum supernatant. *, P<0.05. Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by Tukey’s HSD if
homogeneity of variance was met or Games-Howell if variance was unequal.
doi:10.1371/journal.pone.0173004.g002
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employed. The strongest activation was seen on TLR4 (Fig 1A) and TLR2 (Fig 1B). A. mucini-
phila did not activate TLR5 and TLR9, and only minor activation was seen for NOD2 [32].
TLR2 responses were higher in the presence of A. muciniphila compared to L. plantarum
(Fig 1C), but there was no significant difference between the TLR2 response induced by F.
prausnitzii and A. muciniphila (Fig 1C). However, the TLR2 response towards A. muciniphila
was lower than the induction by the Gram-positive Bifidobacterium breve DSM-20213
(Fig 1C).
TLR4 is an important receptor for recognizing Gram-negative sensitive lipopolysaccharide
(LPS). We first verified the presence of LPS in A. muciniphila by using a protocol to extract
LPS from bacterial cells and applying silver staining to visualize it on a gel (Fig B in S1 File). In
these reporter cell line-experiments both live bacteria and A. muciniphila LPS significantly
stimulated NF-κB dependent secreted embryonic alkaline phosphatase (SEAP) production via
TLR4 (Fig 1A). On top of this, A. muciniphila LPS induced production of IL-8, IL-6 and low
amounts of IL-10 and TNF-α in PBMCs. As expected, A. muciniphila LPS did not induce a
TLR2 response (Fig 1B).
30 kDa outer membrane pili-like protein (Amuc_1100) is a strong TLR2
activator and induces cytokines in PBMCs
A. muciniphila supernatant activated TLR2 as the NF-κB activity persisted while bacteria were
separated from the cell line by a membrane in a Transwell assay (Fig 1D). This indicates A.
muciniphila can activate TLR2 with both cell derived fragments and extracellular molecules.
The main fermentation products in the supernatant of A. muciniphila are acetate and propio-
nate, but no effect on NF-κB activity was observed for these fatty acids at a concentration of 1
mM (Fig C in S1 File). Using centrifugal membrane filters of differing pore sizes, we could
demonstrate that for TLR2 and cytokine induction the size of signaling molecules from the
supernatants had to be larger than 100 kDa (Fig 1E). The production of IL-8, IL-1β, IL-6, IL-
10 and TNF-α by PBMCs increased along with the molecule size of the filtrated supernatant
(Table 1).
Next we separated bacterial membranes from intracellular proteins with sucrose density-
gradient centrifugation. LC-MS/MS-analysis was done on four different fractions along the
gradient to identify the proteins and determine their relative amounts. Two samples (Fraction
1 & 2) separated with sucrose density-gradient centrifugation were found to differ notably in
the relative amount of cell envelope proteins. In total 117 cell envelope proteins were detected
in these fractions, with 84 of them exclusively found in Fraction 1 (Fig 3A). Fraction 1 was
especially enriched for proteins involved in protein transport and secretion, in comparison to
Fraction 2. Fraction 2 had a more heterogeneous protein content based on protein function,
but overall lower diversity of proteins. Among the most abundant proteins in Fraction 2 were
mucin-degrading enzymes (glycosyl hydrolase, beta-galactosidase, N-acetylhexosaminidase)
and other enzymes (alanine-glyoxylate transaminase, hyalurononglucosaminidase). These
fractions were also tested on the TLR2 cell line and PBMCs in equal protein concentrations.
Fraction 1 induced higher TLR2 activity than Fraction 2 (Fig 1F). Fraction 1 also induced
higher cytokine production in PBMCs as compared to Fraction 2 (Table 1).
Based on proteomics analysis with LC–MS/MS we discovered that the relative abundance
of all proteins that were encoded by a gene cluster corresponding to locus tags Amuc_1098 to
Amuc_1102 (Fig 3B), was at least ten times higher in Fraction 1 compared to Fraction 2 (Fig
3C). Previously, we have shown that proteins from this gene cluster are highly abundant also
in the whole proteome of A. muciniphila, with Amuc_1098 being the most abundant outer
membrane protein [24]. Amuc_1098 is predicted to encode a type II and type III secretion
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system protein and Amuc_1101 is predicted to encode a cell division protein FtsA. The other
three genes (Amuc_1099, Amuc_1100, Amuc_1101) are annotated as hypothetical proteins.
All the genes, except for Amuc_1101, have a signal sequence at the N terminus, indicating they
are destined towards the secretory pathway and may be involved in forming the pili-like struc-
tures as described by Derrien et al., 2004 [7]. Recently, administration of the purified recombi-
nant Amuc_1100 protein was shown to improve glucose tolerance and induce a lower body
weight and fat mass gain in mice fed a high-fat diet in comparison to untreated mice on the
same diet [32]. We used immunofluorescence labeling to localize the proteins in the bacteria,
and successfully identified Amuc_1100 (32 kDa) as an outer membrane protein (Fig 4B). How-
ever, some variation was observed in the intensity of the labeling of the A. muciniphila cells
with the anti-Amuc_1100 antibodies (Fig 4B). Similarly, the labeling intensity also varied, but
in a less extensive way, with the whole cell antibody (Fig 4A).
Fig 3. Proteins encoded by the gene cluster Amuc_1098 to Amuc_1102 are found abundantly in a fraction enriched for membrane
and cell-envelope proteins. (A) Number of A. muciniphila membrane and cell-envelope proteins detected with LC-MS/MS in two different
fractions from a sucrose density-gradient separation method. (B) Amuc_1098 to Amuc_1102 gene cluster. (C) Abundance of proteins found in
Fraction 1 vs. Fraction 2. Relative abundances of the proteins are presented on a log10 scale. A log10 relative abundance of 3.5 represents
proteins that were not detected or were under the detection limit.
doi:10.1371/journal.pone.0173004.g003
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Purified recombinant Amuc_1100 protein gave specific induction of TLR2 (Fig 1G) and
was able to induce IL-1β, IL-6, IL-8, IL-10 and TNF-α production in PBMCs (Table 1). As
the genes Amuc_1101 and Amuc_1102 did not lead to overproduced soluble proteins, we
were not able to test the effect of these proteins on the immune response. As a control to
Amuc_1100, secreted enzymes that are involved in A. muciniphila mucin degradation were
tested. It was found that the enzymes Amuc_0451 (sulfatase), Amuc_0625 (exo-alpha-siali-
dase), and Amuc_2136 (glycoside hydrolase) are abundantly produced by A. muciniphila
and dose-dependent TLR2-signaling was detected for each of them (Fig 1H). However, the
TLR2-signaling response tended to be lower for these periplasmic enzymes in comparison to
Amuc_1100.
Fig 4. Amuc_1100 is located on the outer membrane of A. muciniphila. Immunofluorescence staining
of A. muciniphila cells with whole cell antiserum (A) or anti-Amuc_1100 (B) and Alexa-488-conjugated
secondary IgG. Phase-contrast images of the same microscopic fields are shown below. Pictures were
cropped from the original image.
doi:10.1371/journal.pone.0173004.g004
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Additionally, we tested the impact of A. muciniphila and the purified recombinant proteins
on the development of the integrity of epithelial cell layer by determining the TER of Caco-2
monolayers. A. muciniphila showed a significantly increased TEER after 24 h of co-cultivation
with the Caco-2 cells as reported previously [33] (Fig 5). In our assay also Amuc_1100 showed a
significantly increased TEER at 24 h (Fig 5), whereas the other purified proteins (Amuc_2136,
Amuc_0625 and Amuc_0451) did not significantly increase TEER (Fig D in S1 File). E. coli is
known to have adverse effects on epithelial cell monolayer integrity and decreased the TEER
(Fig 5) [34].
Discussion
A. muciniphila MucT was capable of inducing a wide range of immune-modulatory responses
in vitro. The immune modulatory capacity was traced back to large molecule complexes with a
molecular size of over 100 kDa. Subsequently, we showed that a bacterial fraction enriched
in cell envelope proteins, presumably including large structures exposed to the surface of the
bacteria, induced high TLR2 signaling and cytokine production in PBMCs. We showed this
fraction to be highly enriched in a set of proteins encoded by the gene cluster Amuc_1098—
Amuc_1102 that could constitute the pili-like structures observed in electron microscope
images [7]. Amuc_1100 is part of this gene cluster, and its 30-kDa product could be overpro-
duced in E. coli and found to induce production of IL-6, IL-8 and IL-10 in PBMCs. Moreover,
using immunofluorescence microscopy we could localize the Amuc_1100 protein at the out-
side of A. muciniphila cells, compatible with its location in pili-like structures. Some heteroge-
neity in the immunolabeling was observed, possibly reflecting different amounts of pili per
cell. As A. muciniphila is located in the mucus layer, not far from the epithelial cells, it may
benefit from these types of appendages when interacting with the host.
Fig 5. A. muciniphila and outer membrane protein Amuc_1100 increase the development of transepithelial
electrical resistance. The impact of A. muciniphila, purified protein Amuc_1100 (0.05 μg/ml) or E. coli on the
TEER development of Caco-2 monolayer after 24 h of stimulation. Mean and standard deviations from three
parallel wells are shown. Significant differences (p < 0.05) in the TEER values as compared to control (growth
medium without bacteria) at 24 h are indicated with an asterix. Statistical analysis was performed by one-way
analysis of variance (ANOVA).
doi:10.1371/journal.pone.0173004.g005
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In addition, a few secreted mucin-degrading enzymes also activated PBMCs and TLR2. Pre-
viously it was reported that A. muciniphila extracellular vesicles (EV) stimulate IL-6 secretion,
but pre-treatment of a colon epithelial cell line with these EV before treating them with E. coli
EV, decreased IL-6 production as compared to treatment with E. coli EV alone [20]. It is
unclear which proteins are present in the A. muciniphila EV that trigger the response, and
whether mucin fragments from the culture medium may have confounded the results. In our
study A. muciniphila was grown on non-mucus medium for all the immune assays to prevent
compounds of hog gastric mucin from interfering with the immune response.
IL-8, IL-6, IL-1β, IL-10 and TNF-α were induced by A. muciniphila in human derived
PBMCs, indicating it cannot be strictly defined as anti- or pro- inflammatory, but may instead
have a more complex role in preserving the balance of the gut ecosystem. Interestingly, live
bacteria induced significantly higher IL-1β production than heat-killed bacteria, suggesting
that cell derived fragments as well as secreted compounds have an important role in the
immune signaling. The immunomodulatory outer membrane structures may have also been
damaged during the heat treatment. Stimulation of PBMCs with A. muciniphila led to produc-
tion of proinflammatory IL-8. However, a recent study showed that A. muciniphila induced
IL-8 production in enterocytes at 100-fold higher cell concentrations as compared to E. coli,
suggesting a fairly low inflammatory potential in the gut [33].
The immune modulatory effects observed for A. muciniphila were distinct from the micro-
biota members F. prausnitzii A2-165 and L. plantarum WCFS1. Differential host response
towards A. muciniphila and F. prausnitzii also became apparent in a study conducted with
mouse derived organoids [16]. Therein, A. muciniphila triggered mostly regulation of meta-
bolic markers as compared to F. prausnitzii. In the model systems used in the present study A.
muciniphila and F. prausnitzii live cells induced very similar amounts of IL-10. Interestingly,
A. muciniphila supernatant induced high amounts of IL-10, whereas F. prausnitzii supernatant
barely stimulated any IL-10 production. Furthermore, the TNF-α/IL-10 cytokine induction
ratio, which is often used to measure the inflammatory potential of emerging probiotics [35,
36], was lower in A. muciniphila in comparison to F. prausnitzii and L. plantarum. These
observations indicate greater anti-inflammatory capacity for both live A. muciniphila as well as
its secreted products and metabolites in comparison to F. prausnitzii and L. plantarum.
As Amuc_1100 was shown to be located on the outer membrane of A. muciniphila, it is
plausible that this protein is also liberated to the supernatant and therefore contributes to
stimulation of IL-10. Another possibly important difference between the secreted compounds
produced by these two bacteria is the production of mucin-degrading enzymes, which are
abundantly present in A. muciniphila, but not in F. prausnitzii.
The cytokine response of human PBMCs was consistently lower for L. plantarum compared
to A. muciniphila, except for induction of TNF-α. This is in line with the comparison of mouse
transcriptional response to colonization with A. muciniphila or L. plantarum, which revealed
that A. muciniphila induces relatively higher up-regulation of genes participating in immune
response signaling and ERK/MAPK signaling [15]. Despite greater immune response, the A.
muciniphila-colonized mice did not develop microscopically visible inflammation or show any
sign of discomfort. The diverse immune stimulation caused by A. muciniphila could thus be an
indication of gut immune tolerance towards this commensal. The differences between A. muci-
niphila and L. plantarum were also demonstrated in obese and type 2 diabetic mice, where
treatment with A. muciniphila improved the metabolic outcome, whereas treatment with L.
plantarum did not at all have this beneficial effect [17].
The differential immune response between A. muciniphila, F. prausnitzii and L. plantarum
could be an indication of their physiological or metabolic differences, or the fact that in the
gut these bacteria colonize separate niches. As a mucin-degrader, A. muciniphila is in closer
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contact with the host, in contrast to bacteria colonizing the lumen. Our study further strength-
ens the findings made in the aforementioned studies [15–17] on the variances of host response
between these commensal bacteria.
A. muciniphila LPS gave a strong response with TLR4 and is most likely the activating mole-
cule for this receptor in A. muciniphila. Recently it has been reported that the position of the
phosphate in the lipid A of bacterial LPS may play an important role in separating bacterial-
host innate immune system interactions into either symbiotic or pathogenic relationships
[37]. Determining the molecular structure of A. muciniphila LPS would be valuable in under-
standing its immunostimulatory role in the gut. Previously, it was proposed that LPS of A.
muciniphila is inflammatory in a model of experimental alcoholic liver disease in mice, as the
levels of A. muciniphila were higher after chronic intragastric alcohol feeding, and lower in
Muc2-/- mice, along with lower plasma LPS concentration [38].
TLR2 is best known for recognizing lipoteichoic acid (LTA) from Gram-positive bacteria,
but some Gram-negative bacteria containing non-classical LPS have also been shown to signal
through TLR2 [39, 40]. As the lipid structure of A. muciniphila membranes is not characterized
in detail, we evaluated the ability of A. muciniphila LPS to stimulate TLR2. Even though live
bacteria and the supernatant induced a strong TLR2 response, purified LPS did not.
A. muciniphila did not activate TLR5, the intestinal receptor for flagellin, reflecting the
notion that there are no flagellin genes found in the genome of A. muciniphila [41]. Only high
concentrations of A. muciniphila (107 bacteria/well) induced a minor response of the TLR9
receptor, which recognizes unmethylated CpG sequences in DNA molecules. Isolated A. muci-
niphila DNA did not induce any TLR9 response. The genome of A. muciniphila has a lower
than median frequency (255 vs. 401) of GTCGTT hexamers, in comparison with 59 other bac-
terial species [42], which may explain the observed low activation of TLR9. Another explana-
tion may be the intracellular location of TLR9, which makes it more difficult for the ligands to
reach it, especially in an in vitro setting.
The localization of A. muciniphila in the mucus layer, close to the epithelial layer, probably
has had a great impact on the mechanisms of immune modulation this bacterium has devel-
oped. As A. muciniphila is diminished in many inflammatory diseases, it could be speculated
that the absence of A. muciniphila in case of inflammation prevents immune suppression at
the mucosal epithelial border. Cross-talk between A. muciniphila and the host might affect
immunological tolerance and homeostasis within the gut, possibly by keeping the immune sys-
tem alert for potential disruptions. A. muciniphila has been shown to restore mucus layer
thickness and to increase intestinal endocannabinoids in diet-induced obese mice [17], sug-
gesting at the same time it contributes to improving gut barrier function. Here we showed that
A. muciniphila and the outer membrane protein Amuc_1100 increased the development of
TEER in Caco2-cells, which also indicates strengthening of the epithelial barrier function. The
efficacy of the recombinant Amuc_1100 protein to improve gut barrier and restrain the devel-
opment of high-fat diet-induced obesity has recently been demonstrated in mice [32].
Altogether, these results could partially explain the positive correlation between levels of A.
muciniphila and gut health. Several studies have reported depletion of A. muciniphila in the
fecal microbiota of ulcerative colitis patients, both in remission [10, 43] and in clinically active
disease [44]. In addition to fecal microbiota, reduced levels of A. muciniphila have also been
found in biopsies of intestinal mucosa from IBD-patients in comparison to healthy controls [9].
In conclusion, this study revealed the diverse immunostimulatory capacities of A. mucini-
phila and identified candidate bacterial products that mediate this stimulation. We have also
shown that established and next-generation probiotics have a wide range of species-specific
immune stimulatory properties, which should be taken into consideration when developing
new applications and interventions.
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